Showing results (341-350 of 3,507) with videos related to
Sort By:
Pageof 351
BMC Neuroscience|November 29, 2014
Cognitive-behavioral phenotypes of Williams syndrome are associated with genetic variation in the GTF2I gene, in a healthy populationBernard J Crespi, Peter L HurdBrain and Language|June 14, 2017
Segregating polymorphisms of FOXP2 are associated with measures of inner speech, speech fluency and strength of handedness in a healthy populationBernard Crespi, Silven Read, Peter HurdDevelopmental Biology|December 20, 2002
PAR-1 is required for morphogenesis of the Caenorhabditis elegans vulvaDaryl D Hurd, Kenneth J KemphuesBone Marrow Transplantation|September 6, 2006
Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?H D Klepin, D D HurdThe American Journal of Psychiatry|August 3, 2018
Molecular Genetics and New Medication Strategies for Opioid AddictionYasmin L Hurd, Charles P O'BrienPeptides|July 1, 1986
ACTH acts via an anterior ventral third ventricular site to elicit grooming behaviorA J Dunn, R W HurdArthritis and Rheumatism|January 1, 1975
The effect of cyclophosphamide on B and T lymphocytes in patients with connective tissue diseasesE R Hurd, V J GiulianoHealthcare Quarterly (Toronto, Ont.)|October 21, 2010
Skin and wound care excellence: integrating best-practice evidenceKaryn Popovich, Paula Tohm, Theresa HurdJournal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|June 9, 2007
Knee instability after acute ACL rupture affects movement patterns during the mid-stance phase of gaitWendy J Hurd, Lynn Snyder-MacklerJournal of the National Cancer Institute. Monographs|January 1, 1995
Randomized, comparative study of high-dose (with autologous bone marrow support) versus low-dose cyclophosphamide, cisplatin, and carmustine as consolidation to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for patients with operable stage II or III breast cancer involving 10 or more axillary lymph nodes (CALGB Protocol 9082). Cancer and Leukemia Group BD D Hurd, W P PetersPageof 351